This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
September 2026 quarter and half-year revenue and profit rise sharply
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Results for the quarter and half year ended 30 September 2026 were Board approved. Quarterly revenue was Rs 323.58 lakh, up 35.8 percent, and profit after tax was Rs 135.06 lakh, up 91.7 percent. Half-year revenue rose 30.5 percent to Rs 564.49 lakh and profit after tax rose 64.0 percent to Rs 241.98 lakh. Operating cash flow was Rs 499.12 lakh versus negative Rs 2.04 lakh a year earlier. The limited review raised no material concerns.
Strong revenue, profit and cash flow may support the stock, though results are unaudited and include investment and leasing income.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹3.24 Cr | ₹2.38 Cr | +35.9% |
| Operating profit | ₹1.99 Cr | ₹0.62 Cr | +223.6% |
| Profit after tax | ₹1.35 Cr | ₹0.70 Cr | +91.7% |
| EBITDA margin | 67.9% | 34.1% | +33.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.